Novartis forecasts 5% annual sales growth through 2031 and a core operating margin of at least 40% by 2029.
https://finviz.com/stock?t=NVS&p=d
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.